SOURCE: Emergent Health Corporation

April 24, 2008 08:45 ET Initiates Profile Coverage of Emergent Health Corp.

MYRTLE BEACH, SC--(Marketwire - April 24, 2008) - Emergent Health Corp. (PINKSHEETS: EMGN) is a company focused on providing a better health and lifestyle through natural products. Emergent Health Corp.'s flagship products include Hungarest™, a diet aid, a proprietary patent-pending formulation having the unique ability to control appetite both in the stomach and brain. These two mechanisms, acting together, have a cumulative effect greater than any one appetite control mechanism. There is also evidence that the mechanisms continue to exert an effect after the goal weight is attained and the Hungarest™ diet aid is discontinued.

Vita-Stim™, a life-enhancement supplement, is a proprietary patent-pending formulation with the ability to improve the immune system, as well as stimulate stem cells from each consumer's own body mechanism in their bone marrow. There is mounting evidence that a dual acting mechanism can have a positive effect upon many known human conditions.

EMGN also has exciting new products currently in research and development. They continue to develop highly sought after safe and natural remedies to medical issues affecting a large segment of U.S. consumers:

1.   A product for Erectile Dysfunction known in-house as ERDEX.
2.   A product for Peyronies Disease known in-house as PX.
3.   A product designed to enhance hair growth known in-house as Hair-Gain.

Robert Adams, Editor of, says, "Our web site has initiated Profile Coverage of Emergent Health Corp. (PINKSHEETS: EMGN). We feel that Emergent is an exciting new company worth watching. One third of the people in the U.S. are obese which means they are at risk for heart disease, diabetes and some types of cancer. Another third are merely overweight, but still desperate for a drug that will return them to their former high school selves. As natural supplements gain viability and visibility in this $33 billion a year U.S. market for weight-loss, we feel this is a company worth profiling."


To subscribe or get more information, visit our home page located at

We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Robert Adams at 713-401-9333, or via email at

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid for the publication and circulation of this report and other IR services. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information